After LXA4 treatment of the CF cells, the ASL height increased and the disruption of the ASL was eliminated suggesting that LXA4 enhances fluid secretion into the ASL and inhibits mucin secretion by CF airway epithelial cells. This evidence concerns the gene MUC5AC and cystic fibrosis.